NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma

Glioblastoma (GBM) is the most common primary intracranial malignancy. GBM still exhibits high recurrence and mortality rates even following combined treatment with surgery, radiotherapy and chemotherapy, Therefore, the identification of novel therapeutic targets is urgent. Previous research has sho...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Rep
Main Authors: Guo, Qiuyun, Han, Na, Shi, Lei, Yang, Li, Zhang, Xiaoxi, Zhou, Yangmei, Yu, Shiying, Zhang, Mengxian
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2019
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6667917/
https://ncbi.nlm.nih.gov/pubmed/31322259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7227
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki